Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOSEFINA FABIOLA TUR

Allopathic & Osteopathic Physicians General Practice

NPI
1841292695
CMS profile
1212820
Location
MIAMI, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$1,240.72

13 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $896.67 4
Food and Beverage $344.05 9

By paying entity

PY2019 · entire year · sorted by reported total

Paying entityAmountRecords
Eisai Inc. $1,105.47 10
GlaxoSmithKline, LLC. $135.25 3

Page 1 of 1; records 1–13 of 13 matching records. This page contains 13 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JOSEFINA FABIOLA TUR

NPI 1841292695 · CMS profile ID 1212820

Allopathic & Osteopathic Physicians / General Practice

MIAMI, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–13 of 13 matching records. This page contains 13 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1841292695?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JOSEFINA FABIOLA TUR, NPI 1841292695, CMS profile ID 1212820. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–13 of 13 matching records. This page contains 13 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1841292695?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). JOSEFINA FABIOLA TUR, NPI 1841292695, CMS profile ID 1212820. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–13 of 13 matching records. This page contains 13 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1841292695?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
JOSEFINA FABIOLA TUR, NPI 1841292695, CMS profile ID 1212820, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–13 of 13 matching records. This page contains 13 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1841292695?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

13 matching records · $1,240.72 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 13 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–13 of 13.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GlaxoSmithKline, LLC. $6.9511/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670981623 CMS
GlaxoSmithKline, LLC. $6.9408/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671493637 CMS
Eisai Inc. $12.4808/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 698080549 CMS
Eisai Inc. $373.3408/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 698080551 CMS
Eisai Inc. $439.5908/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 698080553 CMS
Eisai Inc. $45.5708/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 698080555 CMS
Eisai Inc. $38.1708/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 698080557 CMS
Eisai Inc. $50.0008/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 698080559 CMS
Eisai Inc. $12.4808/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 698080561 CMS
Eisai Inc. $49.9808/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 698080563 CMS
Eisai Inc. $24.9908/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 698080565 CMS
Eisai Inc. $58.8708/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 698080567 CMS
GlaxoSmithKline, LLC. $121.3604/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670279425 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,240.72 13

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019
Generated from
OP_DTL_GNRL_PGYR2019_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2022 Principal investigator $158,506.76 7
PY2021 Principal investigator $666,042.08 12
PY2020 Principal investigator $1,186,456.26 65
PY2019 Recipient $517.47 7
PY2019 Principal investigator $369,580.16 189

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

12 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Eisai Inc. $68,982.33 12/20/2021 Non-covered Recipient Entity
FINLAY MEDICAL RESEARCH CORP
A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease No dispute reported 06/30/2026 836166629
Principal investigator 1 Eisai Inc. $41,359.22 11/19/2021 Non-covered Recipient Entity
FINLAY MEDICAL RESEARCH CORP
A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease No dispute reported 06/30/2026 836166625
Principal investigator 1 Eisai Inc. $56,818.62 11/19/2021 Non-covered Recipient Entity
FINLAY MEDICAL RESEARCH CORP
A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease No dispute reported 06/30/2026 836166631
Principal investigator 1 Eisai Inc. $56,434.79 10/20/2021 Non-covered Recipient Entity
FINLAY MEDICAL RESEARCH CORP
A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease No dispute reported 06/30/2026 836166633
Principal investigator 1 Eisai Inc. $33,506.61 09/24/2021 Non-covered Recipient Entity
FINLAY MEDICAL RESEARCH CORP
A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease No dispute reported 06/30/2026 836166627
Principal investigator 1 Eisai Inc. $51,638.50 08/20/2021 Non-covered Recipient Entity
FINLAY MEDICAL RESEARCH CORP
A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease No dispute reported 06/30/2026 836166611
Principal investigator 1 Eisai Inc. $43,439.63 07/20/2021 Non-covered Recipient Entity
FINLAY MEDICAL RESEARCH CORP
A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease No dispute reported 06/30/2026 836166619
Principal investigator 1 Eisai Inc. $1,100.18 03/19/2021 Non-covered Recipient Entity
FINLAY MEDICAL RESEARCH CORP
A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease No dispute reported 06/30/2026 836166617
Principal investigator 1 Eisai Inc. $93,250.00 03/10/2021 Non-covered Recipient Entity
FINLAY MEDICAL RESEARCH CORP
A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease No dispute reported 06/30/2026 836166613
Principal investigator 1 Eisai Inc. $73,523.70 03/10/2021 Non-covered Recipient Entity
FINLAY MEDICAL RESEARCH CORP
A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease No dispute reported 06/30/2026 836166615
Principal investigator 1 Eisai Inc. $84,185.50 03/10/2021 Non-covered Recipient Entity
FINLAY MEDICAL RESEARCH CORP
A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease No dispute reported 06/30/2026 836166623
Principal investigator 1 Eisai Inc. $61,803.00 01/19/2021 Non-covered Recipient Entity
FINLAY MEDICAL RESEARCH CORP
A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease No dispute reported 06/30/2026 836166621